glp-1 news today cardiovascular outcomes 2025 november studies add to growing body of evidence demonstrating significant benefit on Frontiers | Glucagon-like peptide-1 receptor

The exact reason why some people experience skin sensitivity is not yet fully understood, but there are several leading theories in the medical community

See the pooled clinical-trial evidence here

Slows gastric emptying, promoting a feeling of fullness

Our team is also working on the next wave of medicines, including a non-incretin injection weight loss drug called eloralintide that is related to an old medicine called pramlintide

Summary Clinical studies highlight that GLP-1RA to treat obesity, alongside their concomitant cardioprotective effects, have become a hallmark in clinical science

This deal extends Atomo's strategic partnership with Burnet Institute